Intraoperative Neuromonitoring Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Intraoperative Neuromonitoring Market By Product and Service  Systems, and Accessories), Source Type(Insourced Monitoring, and Outsourced Monitoring), Modality (Motor Evoked Potentials (MEPs), Somatosensory Evoked Potentials (SSEPs), Electroencephalography (EEG), Electromyography (EMG), Brainstem Auditory Evoked Potentials (BAEPs), and Visual Evoked Potentials (VEPs)), Application Type (Spinal Surgery, Neurosurgery, Vascular Surgery, ENT Surgery, Orthopedic Surgery, and Other Surgeries), End User (Hospitals, and  Ambulatory Surgical Centers) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Intraoperative Neuromonitoring Market size is expected to be valued at USD 5,218.1 million in 2022, growing at a 7.3% CAGR from 2022 to 2028. Intraoperative neuromonitoring is a technique that reduces the risk of neurological effects during and after surgeries involving the nervous system. An intraoperative neuromonitoring system uses soundtracks of potentials (such as EEG, EMG, and evoked potentials) from the nervous system during a surgical practice. The use of neuromonitoring is significant during surgeries as it assists in the detection of injuries before they become so severe, resulting in postoperative complications in the patients. Therefore, the intraoperative neuromonitoring system reduces the risk of debilitating deficits such as paralysis, muscle weakness, hearing loss, and other ordinary body functions.  The increasing geriatric population worldwide, rise in prevalence of chronic disorders, a wide range of applications of intraoperative neuromonitoring techniques in several surgeries, and controlling the risk through intraoperative neuromonitoring during complex surgeries. These are some major factors that drive the market. However, the market growth is hindered due to the dearth of skilled professionals and lack of awareness of intraoperative neuromonitoring techniques in developing countries. On the other hand, an upsurge in medical tourism and growth opportunities in the emerging economies of the Asia-Pacific regions are anticipated to create numerous opportunities for market growth during the forecast period. Furthermore, technological development of devices, such as neurosurgery devices, surgical microscopes, ophthalmic surgical devices, and surgical robots, has led to a drop in direct human interference in surgical procedures, which is further expected to support the market growth in the coming next few years. For instance, in October 2020, Medtronic plc received 510(k) approval from the United States Food and Drug Administration for the NIM Vital nerve monitoring system, which permits physicians to detect, monitor, and confirm nerve function, to support reducing the risk of nerve damage during head & neck surgeries.

Intraoperative Neuromonitoring Market

MARKET SUMMARY
-
7.3%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.3%
  • Largest Market– Asia Pacific
  • Fastest Growing Market–  North America

Intraoperative Neuromonitoring Market

  • The intraoperative neuromonitoring market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The intraoperative neuromonitoring market is segmented based on based on product and service, source type, modality, application, end user, and geography.
Key Players
  • Neuro Style.
  • Nihon Kohden Corporation
  • Nuvasive Inc.
  • Specialty Care Inc.
  • Technomed
  • Accurate Monitoring
Intraoperative Neuromonitoring Market Dynamics

The market for intraoperative neuromonitoring is driven by the rising prevalence of chronic diseases associated with various lifestyles, such as neurological and cardiovascular conditions. As per the International Diabetes Federation Diabetes Atlas Tenth edition, in December 2021, around 537 million adults all over the world were found to have diabetes in 2021; with the numbers expected to raise to 643 million by 2030 and 783 million by 2045. Furthermore, according to the Australian Bureau of Statistics released in March 2022, almost half of Australians of all ages group (46.6%) had one or more chronic conditions, and approx. one in five (18.6%) had two or more chronic conditions. Approx half (49.0%) of all females had one or more chronic conditions, and one in five (20.7%) had two or more. Also, 43.9% of males had one or more chronic conditions and 16.4% had two or more. This will surely increase the adoption of intraoperative neuromonitoring techniques all over the world which has significantly contributed to the growth of this market over the forecasted period.


North-America Got Significant Share

Intraoperative Neuromonitoring Market

North America is expected to dominate the market over the forecasted period owing to the presence of main market players. A favourable and constantly improving reimbursement in this region has prompted the regional market. Many neurological centers in the United States mostly recommend the use of intraoperative neuromonitoring techniques and make effort to fulfill the workforce gap to meet the demand. Moreover, well-defined guidelines help in intraoperative neuromonitoring techniques during various surgeries procedures resulting in better outcomes, thus benefitting the patients and hospitals. This wide range acceptance of intraoperative neuromonitoring techniques in this developed region undoubtedly leads to the expansion of the global intraoperative neuromonitoring market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The intraoperative neuromonitoring market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Intraoperative Neuromonitoring Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

Intraoperative neuromonitoring is a technique that reduces the risk of neurological effects during and after surgeries involving the nervous system. An intraoperative neuromonitoring system uses soundtracks of potentials (such as EEG, EMG, and evoked potentials) from the nervous system during a surgical practice

Based on the source type, the outsourcing monitoring segment accounts for a significant market share, and it is expected to register the highest CAGR over the forecasted period.

Computational Diagnostics Inc., Inomed Medizintechnik GmbH, Neuro Alert, Medtronic PLC, Natus Medical Incorporated, Neuro Style., Nihon Kohden Corporation.

A rise in the prevalence of chronic disorders, such as stroke, epilepsy, Alzheimer’s disease, and Parkinson’s disease, and the growing emphasis on patient safety during complex surgical procedures


Report

Table Of Content

1. Executive Summary
2. Global Intraoperative Neuromonitoring Market Introduction
2.1. Global Intraoperative Neuromonitoring Market – Taxonomy
2.2. Global Intraoperative Neuromonitoring Market –Definitions
2.2.1. Product and Service
2.2.2. Source Type
2.2.3. Modality
2.2.4. Application
2.2.5. End user
2.2.6. Region
3. Global Intraoperative Neuromonitoring Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Intraoperative Neuromonitoring Market Dynamic Factors – Impact Analysis
3.6. Global Intraoperative Neuromonitoring Market – Competition Landscape
4. Global Intraoperative Neuromonitoring Market Analysis,2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Intraoperative Neuromonitoring Market, By Product and Service, 2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
5.1. Systems
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Accessories
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Services
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Intraoperative Neuromonitoring Market, By Source Type, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Insourced Monitoring
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Outsourced Monitoring
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Intraoperative Neuromonitoring Market Forecast, By Modality, 2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
7.1. Motor Evoked Potentials (MEPs)
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Somatosensory Evoked Potentials (SSEPs)
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Electroencephalography (EEG)
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Electromyography (EMG)
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Brainstem Auditory Evoked Potentials (BAEPs)
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Visual Evoked Potentials (VEPs)
7.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Intraoperative Neuromonitoring Market Forecast, By Application, 2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
8.1. Spinal Surgery
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Neurosurgery
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Vascular Surgery
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. ENT Surgery
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Orthopedic Surgery
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Other Surgeries
8.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.6.3. Market Opportunity Analysis
9. Global Intraoperative Neuromonitoring Market Forecast, By End User,2017–2021 and Forecast, 2022–2028 (Revenue, USD Mn)
9.1. Hospitals
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Ambulatory Surgical Centers (ASCs)
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
10. Global Intraoperative Neuromonitoring Market Forecast, By Region, 2017–2021 and Forecast, 2022–2028(Revenue, USD Mn)
10.1. North America
10.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Intraoperative Neuromonitoring Market – Opportunity Analysis Index, By Product and Service, Source Type, Modality, Application, End user, and Region, 2022 – 2028
11. North America Intraoperative Neuromonitoring market analysis,2017–2021 and Forecast, 2022–2028(Revenue, USD Mn)
11.1. Product and Service Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Systems
11.1.2. Accessories
11.1.3. Services
11.2. Source Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Insourced Monitoring
11.2.2. Outsourced Monitoring
11.3. Modality Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Motor Evoked Potentials (MEPs)
11.3.2. Somatosensory Evoked Potentials (SSEPs)
11.3.3. Electroencephalography (EEG)
11.3.4. Electromyography (EMG)
11.3.5. Brainstem Auditory Evoked Potentials (BAEPs)
11.3.6. Visual Evoked Potentials (VEPs)
11.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Spinal Surgery
11.4.2. Neurosurgery
11.4.3. Vascular Surgery
11.4.4. ENT Surgery
11.4.5. Orthopedic Surgery
11.4.6. Other Surgeries
11.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers (ASCs)
11.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.6.1. USA
11.6.2. Canada
11.7. North America Intraoperative Neuromonitoring Market – Opportunity Analysis Index, By Product and Service, Source Type, Modality, Application, End user, and Country, 2022 – 2028
11.8. North America Intraoperative Neuromonitoring Market Dynamics – Trends
12. Europe Intraoperative Neuromonitoring Market Analysis, 2017–2021 and Forecast, 2022–2028(Revenue, USD Mn)
12.1. Product and Service Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Systems
12.1.2. Accessories
12.1.3. Services
12.2. Source Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Insourced Monitoring
12.2.2. Outsourced Monitoring
12.3. Modality Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Motor Evoked Potentials (MEPs)
12.3.2. Somatosensory Evoked Potentials (SSEPs)
12.3.3. Electroencephalography (EEG)
12.3.4. Electromyography (EMG)
12.3.5. Brainstem Auditory Evoked Potentials (BAEPs)
12.3.6. Visual Evoked Potentials (VEPs)
12.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Spinal Surgery
12.4.2. Neurosurgery
12.4.3. Vascular Surgery
12.4.4. ENT Surgery
12.4.5. Orthopedic Surgery
12.4.6. Other Surgeries
12.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers (ASCs)
12.6. Country Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Russia
12.6.7. Poland
12.6.8. Rest of Europe
12.7. Europe Intraoperative Neuromonitoring Market – Opportunity Analysis Index, By Product and Service, Source Type, Modality, Application,  End User, and Country, 2022 – 2028
12.8. Europe Intraoperative Neuromonitoring Market Dynamics – Trends
13. Asia-Pacific Intraoperative Neuromonitoring Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Product and Service Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Systems
13.1.2. Accessories
13.1.3. Services
13.2. Source Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Insourced Monitoring
13.2.2. Outsourced Monitoring
13.3. Modality Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Motor Evoked Potentials (MEPs)
13.3.2. Somatosensory Evoked Potentials (SSEPs)
13.3.3. Electroencephalography (EEG)
13.3.4. Electromyography (EMG)
13.3.5. Brainstem Auditory Evoked Potentials (BAEPs)
13.3.6. Visual Evoked Potentials (VEPs)
13.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Spinal Surgery
13.4.2. Neurosurgery
13.4.3. Vascular Surgery
13.4.4. ENT Surgery
13.4.5. Orthopedic Surgery
13.4.6. Other Surgeries
13.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers (ASCs)
13.6. Country Analysis2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. ASEAN
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia-Pacific
13.7. Asia-Pacific Intraoperative Neuromonitoring Market – Opportunity Analysis Index, By Product and Service, Source Type, Modality, Application, End user, and Country,2022 – 2028
13.8. Asia-Pacific Intraoperative Neuromonitoring Market Dynamics – Trends
14. Latin America Intraoperative Neuromonitoring Market Analysis,2017 – 2021 and Forecast, 2022–2028(Revenue, USD Mn)
14.1. Product and Service Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Systems
14.1.2. Accessories
14.1.3. Services
14.2. Source Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Insourced Monitoring
14.2.2. Outsourced Monitoring
14.3. Modality Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Motor Evoked Potentials (MEPs)
14.3.2. Somatosensory Evoked Potentials (SSEPs)
14.3.3. Electroencephalography (EEG)
14.3.4. Electromyography (EMG)
14.3.5. Brainstem Auditory Evoked Potentials (BAEPs)
14.3.6. Visual Evoked Potentials (VEPs)
14.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Spinal Surgery
14.4.2. Neurosurgery
14.4.3. Vascular Surgery
14.4.4. ENT Surgery
14.4.5. Orthopedic Surgery
14.4.6. Other Surgeries
14.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers (ASCs)
14.6. Country Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Argentina
14.6.4. Rest of Latin America
14.7. Latin America Intraoperative Neuromonitoring Market – Opportunity Analysis Index, By Product and Service, Source Type, Modality, Application, End user, and Country, 2022 – 2028
14.8. Latin America Intraoperative Neuromonitoring Market Dynamics – Trends
15. Middle East and Africa Intraoperative Neuromonitoring Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
15.1. Product and Service Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.1.1. Systems
15.1.2. Accessories
15.1.3. Services
15.2. Source Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.2.1. Insourced Monitoring
15.2.2. Outsourced Monitoring
15.3. Modality Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Motor Evoked Potentials (MEPs)
15.3.2. Somatosensory Evoked Potentials (SSEPs)
15.3.3. Electroencephalography (EEG)
15.3.4. Electromyography (EMG)
15.3.5. Brainstem Auditory Evoked Potentials (BAEPs)
15.3.6. Visual Evoked Potentials (VEPs)
15.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.4.1. Spinal Surgery
15.4.2. Neurosurgery
15.4.3. Vascular Surgery
15.4.4. ENT Surgery
15.4.5. Orthopedic Surgery
15.4.6. Other Surgeries
15.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers (ASCs)
15.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
15.6.1. Gulf Cooperation Council (GCC) Countries
15.6.2. Israel
15.6.3. South Africa
15.6.4. Rest of MEA
15.7. MEA Intraoperative Neuromonitoring Market – Opportunity Analysis Index, By Product and Service, Source Type, Modality, Application, End user, and Country, 2022 – 2028
15.8. MEA Intraoperative Neuromonitoring Market Dynamics – Trends
16. Competition Landscape
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Product and Service, Source Type, Modality& Service Testing Types, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Computational Diagnostics Inc.
16.2.2.  Inomed Medizintechnik GmbH
16.2.3.  Neuro Alert
16.2.4. Medtronic PLC
16.2.5. Natus Medical Incorporated
16.2.6. Neuro Style.
16.2.7. Nihon Kohden Corporation
16.2.8. Nuvasive Inc.
16.2.9. Specialty Care Inc.
16.2.10.  Technomed
16.2.11.  Accurate Monitoring
16.2.12. NeuroMonitoring Technologies
16.2.13. Group Co., Ltd.
16.2.14. Florim Ceramiche S.p.A
17. Research Methodology
18. Key Assumptions and Acronyms

Report

Company Profile

  • Computational Diagnostics Inc.
  • Inomed Medizintechnik GmbH
  • Neuro Alert
  • Medtronic PLC
  • Natus Medical Incorporated
  • Neuro Style.
  • Nihon Kohden Corporation
  • Nuvasive Inc.
  • Specialty Care Inc.
  • Technomed
  • Accurate Monitoring
  • Neuro Monitoring Technologies
  • Group Co., Ltd.
  • Florim Ceramiche S.p.A

Description

Intraoperative Neuromonitoring Market size is expected to be valued at USD 5,218.1 million in 2022, growing at a 7.3% CAGR from 2022 to 2028. Intraoperative neuromonitoring is a technique that reduces the risk of neurological effects during and after surgeries involving the nervous system. An intraoperative neuromonitoring system uses soundtracks of potentials (such as EEG, EMG, and evoked potentials) from the nervous system during a surgical practice. The use of neuromonitoring is significant during surgeries as it assists in the detection of injuries before they become so severe, resulting in postoperative complications in the patients. Therefore, the intraoperative neuromonitoring system reduces the risk of debilitating deficits such as paralysis, muscle weakness, hearing loss, and other ordinary body functions.  The increasing geriatric population worldwide, rise in prevalence of chronic disorders, a wide range of applications of intraoperative neuromonitoring techniques in several surgeries, and controlling the risk through intraoperative neuromonitoring during complex surgeries. These are some major factors that drive the market. However, the market growth is hindered due to the dearth of skilled professionals and lack of awareness of intraoperative neuromonitoring techniques in developing countries. On the other hand, an upsurge in medical tourism and growth opportunities in the emerging economies of the Asia-Pacific regions are anticipated to create numerous opportunities for market growth during the forecast period. Furthermore, technological development of devices, such as neurosurgery devices, surgical microscopes, ophthalmic surgical devices, and surgical robots, has led to a drop in direct human interference in surgical procedures, which is further expected to support the market growth in the coming next few years. For instance, in October 2020, Medtronic plc received 510(k) approval from the United States Food and Drug Administration for the NIM Vital nerve monitoring system, which permits physicians to detect, monitor, and confirm nerve function, to support reducing the risk of nerve damage during head & neck surgeries.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX